HIFU for Prostate Cancer in Kuala Lumpur
A focused treatment option for selected men with localised prostate cancer, considered after careful review of MRI findings, biopsy results, PSA level, and treatment goals.
High-Intensity Focused Ultrasound as a Focal Treatment Option
High-Intensity Focused Ultrasound, or HIFU, is a minimally invasive treatment that uses focused ultrasound energy to heat and destroy targeted areas of prostate tissue.
In prostate cancer care, HIFU is usually discussed as a form of focal therapy — meaning treatment is directed at a specific area of cancer within the prostate, rather than removing or treating the whole gland.
HIFU is not suitable for every man with prostate cancer. Careful assessment with MRI, biopsy results, PSA level, cancer grade, cancer location, and overall treatment goals is essential before deciding whether this approach may be appropriate.
At a Glance
| Key Point | What It Means |
|---|---|
| Treatment type | Minimally invasive focal therapy |
| Main use | Selected localised prostate cancer |
| How it works | Focused ultrasound energy heats and destroys targeted tissue |
| Hospital stay | Often performed as a day or short-stay procedure, depending on centre protocol |
| Potential advantage | May reduce impact on urinary control and sexual function in carefully selected men |
| Follow-up | PSA monitoring, MRI, and sometimes repeat biopsy may be needed |
What Is HIFU?
HIFU stands for High-Intensity Focused Ultrasound.
During treatment, ultrasound energy is focused onto a planned area within the prostate. This creates heat at the target zone, destroying prostate tissue in that area while aiming to limit damage to surrounding structures.
For prostate cancer, HIFU may be used as:
- Focal HIFU – treating only the cancer-containing part of the prostate
- Hemi-gland HIFU – treating one side of the prostate
- Whole-gland HIFU – treating the whole prostate, less commonly used in modern focal treatment discussions
In prostate cancer care, most discussion around HIFU relates to focal treatment, where only the known cancer-containing area is treated.
Who May Be Suitable for HIFU?
HIFU may be considered in carefully selected men with localised prostate cancer, where the cancer appears confined to the prostate and can be clearly identified on imaging and biopsy.
Suitability depends on several factors, including:
- MRI findings
- Prostate biopsy results
- Gleason score / Grade Group
- PSA level
- Cancer size, location, and number of areas involved
- Prostate size and anatomy
- Baseline urinary and sexual function
- Whether the cancer is low, intermediate, or higher risk
- The patient’s priorities and willingness for close follow-up
HIFU is generally not appropriate when prostate cancer has spread outside the prostate or when disease is too extensive to safely target with focal treatment.
Important to Know
HIFU is not chosen based on preference alone. Suitability depends on whether the cancer can be clearly seen, accurately targeted, and safely monitored after treatment.
Why Some Men Consider HIFU
Some men diagnosed with localised prostate cancer ask about HIFU because it offers a more targeted approach than treatments that involve the whole prostate gland.
In carefully selected cases, HIFU may be considered with the aim of treating the known cancer area while reducing treatment to surrounding healthy prostate tissue. This may be relevant for men who are particularly concerned about urinary control, sexual function, recovery time, or the impact of treatment on quality of life.
However, HIFU is not simply a “less invasive alternative” to surgery or radiotherapy. Its suitability depends on whether the cancer can be accurately identified, safely targeted, and appropriately monitored after treatment.
Important factors include:
- The location and size of the cancer on MRI
- Biopsy findings, including Gleason score or Grade Group
- Whether cancer is present in one area or multiple areas
- PSA level and PSA density
- Prostate size and anatomy
- Baseline urinary and sexual function
- The patient’s priorities and willingness for long-term follow-up
The decision to consider HIFU should be made after a balanced discussion of expected benefits, limitations, alternative treatments, and the possibility that further treatment may be needed in the future.
Important Limitations to Understand
HIFU should be discussed carefully because it is not the same as removing the prostate.
Unlike radical prostatectomy, the prostate remains in the body. This means:
- Untreated prostate tissue remains
- PSA does not usually fall to zero
- Cancer may recur in the treated area
- Cancer may develop or progress in another part of the prostate
- Long-term monitoring is essential
- Further treatment may still be needed later
HIFU Compared With Other Prostate Cancer Treatments
| Treatment Option | Main Approach | Key Consideration |
|---|---|---|
| Active surveillance | Monitoring without immediate treatment | Suitable for selected low-risk cancers |
| Robotic prostatectomy | Surgical removal of the prostate | Offers whole-gland treatment and full pathology |
| Radiotherapy | Treats the prostate using radiation | Non-surgical whole-gland treatment |
| Focal HIFU | Treats selected cancer area only | Targeted treatment, but requires structured long-term follow-up |
| Hormonal therapy | Controls cancer growth using testosterone suppression | Often used with radiotherapy or advanced disease |
What Happens Before HIFU?
Before HIFU is considered, assessment usually includes:
- PSA blood test
- Multiparametric prostate MRI
- Targeted and systematic prostate biopsy
- Review of cancer grade and stage
- Discussion in a multidisciplinary setting where appropriate
- Counselling about alternatives, risks, and follow-up
The aim is to confirm whether the cancer is truly suitable for focal treatment and whether HIFU is a reasonable option compared with surgery, radiotherapy, or surveillance.
What Happens During HIFU?
HIFU is usually performed under general anaesthesia.
A probe is placed through the rectum to deliver focused ultrasound energy to the planned treatment area in the prostate. Imaging guidance is used to help position and monitor the treatment. A urinary catheter may be needed temporarily after the procedure.
The exact technique, treatment area, and recovery plan may vary depending on the treating centre and the patient’s anatomy.
Recovery After HIFU
Recovery is usually shorter than after major surgery, but some temporary urinary symptoms can occur.
Possible short-term effects include:
- Burning or discomfort when passing urine
- Increased urinary frequency or urgency
- Blood in the urine or semen
- Temporary difficulty passing urine
- Need for a catheter for a short period
- Urinary tract infection
Most men require follow-up to monitor symptoms, PSA levels, and treatment response.
Follow-Up After HIFU Is Essential
Follow-up after HIFU is an important part of treatment, not an optional extra.
Unlike prostate removal surgery, the prostate remains in the body after HIFU. This means PSA levels usually do not fall to zero, and PSA results need to be interpreted differently. Ongoing monitoring is required to assess treatment response and to look for any signs of persistent or recurrent cancer.
Follow-up may include:
- Regular PSA blood tests
- Review of urinary and sexual function
- Repeat prostate MRI
- Repeat prostate biopsy in selected cases
- Discussion of further treatment if cancer persists, recurs, or progresses
This is important because cancer may occasionally remain in the treated area, return later, or be found in another part of the prostate that was not treated.
Men considering HIFU should understand that focal treatment usually requires structured long-term surveillance. The success of treatment depends not only on the procedure itself, but also on careful follow-up afterwards.
When to Seek Specialist Assessment
A specialist urology assessment may be helpful if you have been diagnosed with localised prostate cancer and wish to understand whether focal therapy may be appropriate.
HIFU is only one of several treatment options. The most suitable approach depends on balancing cancer control, urinary function, sexual function, recovery, long-term monitoring, and personal priorities.
Discussing HIFU and Prostate Cancer Treatment Options
Choosing treatment for prostate cancer requires careful interpretation of MRI findings, biopsy results, PSA level, cancer risk, prostate anatomy, and personal priorities.
HIFU may be considered for selected men with localised prostate cancer, but it is not suitable for everyone. A detailed consultation can help clarify whether focal treatment, active surveillance, surgery, radiotherapy, or another approach is more appropriate.
Dr Roger Anthony Idi, Consultant Urologist, provides assessment and counselling for men with prostate cancer, including discussion of focal treatment suitability where relevant.
Appointments are arranged through Prince Court Medical Centre.